CymitQuimica logo
Apoptose

Apoptose

Les inhibiteurs de l'apoptose sont des composés qui empêchent ou retardent le processus de mort cellulaire programmée, connu sous le nom d'apoptose. Ces inhibiteurs sont essentiels pour étudier les mécanismes de survie cellulaire et sont utilisés pour enquêter sur les maladies où l'apoptose est dysrégulée, telles que le cancer, les troubles neurodégénératifs et les maladies auto-immunes. En modulant l'apoptose, ces inhibiteurs peuvent aider au développement de thérapies visant à contrôler la mort cellulaire. Chez CymitQuimica, nous offrons une sélection complète d'inhibiteurs de l'apoptose de haute qualité pour soutenir vos recherches en biologie cellulaire, oncologie et domaines connexes.

Sous-catégories appartenant à la catégorie "Apoptose"

Affichez 6 plus de sous-catégories

6026 produits trouvés pour "Apoptose"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • PZ671


    PZ671 is a potent PROTAC degrader targeting Bcl-xL, exhibiting an IC50 of 1.3 nM in MOLT-4 cells and a DC50 of 0.9 nM for Bcl-xL. It induces apoptosis in MOLT-4 cells and effectively inhibits tumor growth in MOLT-4 xenograft mice, while quickly restoring transiently reduced platelet counts. PZ671 is applicable in cancer research, including studies on small cell lung cancer.
    Couleur et forme :Odour Solid

    Ref: TM-T211544

    10mg
    À demander
    50mg
    À demander
  • Tat-ASIC1a (1-20) (mouse, rat)


    Tat-ASIC1a (1-20) (mouse, rat) is a competitive ASIC1a transmembrane peptide with significant neuroprotective effects. It alleviates acidotoxic neuronal damage by targeting the ASIC1a-RIPK1 pathway and an auto-inhibition mechanism. This compound effectively safeguards the brain in ischemic stroke mouse models against damage from ischemia and is applicable in research on neurodegenerative diseases, such as Huntington's disease and Parkinson’s disease.
    Couleur et forme :Odour Solid

    Ref: TM-TP3781

    10mg
    À demander
    50mg
    À demander
  • Angiogenesis inhibitor 3

    CAS :
    Angiogenesis Inhibitor 3 (compound 8) is a potent anti-cancer agent, blocking HUVEC/HCT-15 cell growth and inducing apoptosis.
    Formule :C44H42BrN3O9
    Couleur et forme :Solid
    Masse moléculaire :836.72

    Ref: TM-T74627

    5mg
    À demander
    50mg
    À demander
  • BC13


    BC13 is a CDK6/BRD4 inhibitor with IC50 values of 234 nM for CDK6 and 36 nM for BRD4. It exhibits antiproliferative properties, induces apoptosis (cell death) and DNA damage, and elevates ROS levels.
    Formule :C37H39N7O5
    Couleur et forme :Solid
    Masse moléculaire :661.75

    Ref: TM-T204938

    10mg
    À demander
    50mg
    À demander
  • Bcl-2/Mcl-1-IN-4


    Bcl-2/Mcl-1-IN-4 (compound 20) acts as a dual inhibitor targeting Bcl-2 (Ki=0.49 μM) and Mcl-1 (Ki=0.51 μM). This compound effectively suppresses cancer cell proliferation and induces apoptosis in U937 cells. It is utilized in cancer research.
    Couleur et forme :Odour Solid

    Ref: TM-T89042

    10mg
    À demander
    50mg
    À demander
  • DP-15

    CAS :
    DP-15 acts as a degrader of GSPT1 and BRD4, with DC50 values of 5.25 nM and 0.48 nM, respectively. This compound exhibits antiproliferative activity in AML and NHL cells, showing IC50 values in the nanomolar range, induces G1 phase cell cycle arrest, and triggers apoptosis in MOLM13 cells. Additionally, DP-15 demonstrates anti-leukemic properties in the MOLM-13 xenograft mouse model. [Pink: ligand for target protein JQ-1 carboxylic acid; Black: linker; Blue: ligand for E3 ligaseCereblonThalidomide-5-OH]
    Formule :C42H44ClN9O5S
    Couleur et forme :Solid
    Masse moléculaire :822.374

    Ref: TM-T205043

    10mg
    À demander
    50mg
    À demander
  • Fludarabine triphosphate

    CAS :
    Fludarabine triphosphate inhibits key enzymes, causing cell death.
    Formule :C10H15FN5O13P3
    Couleur et forme :Solid
    Masse moléculaire :525.17

    Ref: TM-T40862

    25mg
    1.369,00€
  • VEGFR-2-IN-61


    VEGFR-2-IN-61 (Compound 7b) is an inhibitor of VEGFR-2 with an IC50 of 2.83 µM. It effectively inhibits the proliferation of various cancer cells, including MCF-7 cells, with an IC50 of 2.12 µM. Additionally, VEGFR-2-IN-61 suppresses cell migration and induces oxidative stress and apoptosis in MCF-7 cells.
    Formule :C27H25N5O
    Couleur et forme :Solid
    Masse moléculaire :435.52

    Ref: TM-T204905

    10mg
    À demander
    50mg
    À demander
  • ARI-1


    ARI-1 is a receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitor that binds to ROR1's extracellular Frizzled domain, effectively inhibiting aberrant
    Couleur et forme :Odour Solid

    Ref: TM-T82971

    5mg
    À demander
    50mg
    À demander
  • AMPK-IN-6


    AMPK-IN-6 (compound 13a) is a potent AMPK inhibitor with an IC50 value of 0.093 µM. It induces apoptosis and suppresses autophagy. Additionally, AMPK-IN-6 exhibits antiproliferative activity and holds potential for research into pulmonary arterial hypertension.
    Formule :C18H20FN5O
    Couleur et forme :Solid
    Masse moléculaire :341.383

    Ref: TM-T204944

    10mg
    À demander
    50mg
    À demander
  • F3-PEG8-RiboTAC


    F3-PEG8-RiboTAC is a RiboTAC compound that specifically degrades the mRNA of the oncogene LGALS1. This compound can induce apoptosis (cell death) in tumor cells and inhibit their invasion. F3-PEG8-RiboTAC exhibits antitumor activity and is applicable in research on leukemia and triple-negative breast cancer. (RNase L ligand; RNA binder; Linker)
    Couleur et forme :Odour Solid

    Ref: TM-T210643

    10mg
    À demander
    50mg
    À demander
  • TNF-α-IN-11


    TNF-α-IN-11 (Compound 10) is a TNF-α inhibitor exhibiting a dissociation constant (K D) of 12.06 μM.
    Formule :C24H26N2O5
    Couleur et forme :Solid
    Masse moléculaire :422.47

    Ref: TM-T78730

    5mg
    À demander
    50mg
    À demander
  • Thymocartin Acetate

    CAS :
    Thymocartin Acetate, a thymopoietin fragment (32-35), inhibits enzyme breakdown; potential for immunodeficiency treatment.
    Formule :C23H44N8O9
    Couleur et forme :Soild
    Masse moléculaire :576.64

    Ref: TM-T34866L

    1mg
    279,00€
    5mg
    702,00€
    10mg
    1.063,00€
    25mg
    2.075,00€
    50mg
    2.817,00€
    100mg
    3.750,00€
  • dASK1

    CAS :
    dASK1 is a selective CRBN-based PROTAC degrader targeting apoptosis signal-regulating kinase 1 (ASK1). It forms a stable ternary complex with ASK1, facilitating its rapid and sustained degradation via the ubiquitin-proteasome pathway. dASK1 exhibits strong ASK1 degradation capabilities and is applicable for hepatitis research.
    Formule :C38H38F2N10O8
    Couleur et forme :Solid
    Masse moléculaire :800.77

    Ref: TM-T211263

    10mg
    À demander
    50mg
    À demander
  • Cytostatin

    CAS :
    Cytostatin: Natural antitumor, inhibits cell adhesion, blocks B16 melanoma, induces apoptosis, selectively targets PP2A (IC50 = 29 nM).
    Formule :C21H33O7P
    Couleur et forme :Solid
    Masse moléculaire :428.462

    Ref: TM-T37055

    1mg
    À demander
  • RIPK1 ligand-Linker Conjugate-1


    RIPK1ligand-Linker Conjugate-1 is a Target Protein Ligand-Linker Conjugate that consists of a RIPK1 ligand and a PROTAC linker, designed to recruit E3 ligase. It is utilized in the synthesis of PROTACRIPK1Degrader-1.
    Couleur et forme :Odour Solid

    Ref: TM-T212290

    10mg
    À demander
    50mg
    À demander
  • LY 219703

    CAS :
    LY 219703 is a photoactivatable diarylsulfonylurea.
    Formule :C13H10ClN5O3S
    Couleur et forme :Solid
    Masse moléculaire :351.77

    Ref: TM-T32993

    25mg
    1.369,00€
  • E3 ligase Ligand 36

    CAS :
    E3 ligase Ligand 36 is an E3 ligase ligand that can be utilized for synthesizing PROTACs, such as PROTAC BRM/BRG1 degrader-1.
    Formule :C25H30N4O5S
    Couleur et forme :Solid
    Masse moléculaire :498.6

    Ref: TM-T201850

    10mg
    À demander
    50mg
    À demander
  • TNF-α/IL-1β-IN-1


    TNF-α/IL-1β-IN-1 (compound 11a) is an anti-inflammatory agent that effectively reduces the expression of TNF-α and IL-1β, inhibits oxidative stress and myocardial cell apoptosis, and demonstrates significant activity against septic myocardial injury. Additionally, it improves myocardial blood flow in vivo.
    Formule :C41H58N2O7
    Couleur et forme :Solid
    Masse moléculaire :690.91

    Ref: TM-T201182

    10mg
    À demander
    50mg
    À demander
  • EGFR-IN-169


    EGFR-IN-169 is an epidermal growth factor receptor (EGFR) inhibitor derived from ginsenoside, with an IC50 of 5.19 μM. It disrupts colorectal cancer cell migration and growth by inhibiting the EGFR-mediated RalA/EMT pathway. With an IC50 of 4.46 μM against HCT-116 cells and a selectivity index (SI) of 16.92, EGFR-IN-169 also inhibits CDKs, induces G0/G1 cell cycle arrest, and suppresses cell migration and invasion. Additionally, EGFR-IN-169 reduces mitochondrial membrane potential, induces apoptosis and reactive oxygen species (ROS) production. It is applicable in cancer research, particularly for colorectal cancer.
    Couleur et forme :Odour Solid

    Ref: TM-T212564

    10mg
    À demander
    50mg
    À demander